Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

10.28
Delayed Data
As of 11:35am ET
 -0.11 / -1.06%
Today’s Change
7.41
Today|||52-Week Range
23.11
-24.52%
Year-to-Date

Today’s Trading

Previous close10.39
Today’s open10.41
Day’s range10.26 - 10.49
Volume94,705
Average volume (3 months)766,870
Market cap$345.2M
Dividend yield--
Data as of 11:35am ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-39.67%
Earnings growth (this year)-15.06%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.59%
P/E ratioNM
Price/Sales946.06
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp+0.01+0.24%
BTXBioTime Inc-0.03-1.14%
NSTGNanoString Technolog...-0.31-3.03%
SELBSelecta Biosciences ...-0.48-2.25%
Data as of 11:50am ET, 10/23/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$388.0K
Annual profit (last year)-$69.2M
Net profit margin-17,845.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard A. Fair
Chief Financial Officer &
Treasurer
Alan A. Musso
Corporate headquarters
Houston, Texas

Forecasts